TUXIS CORP
NSAR-A, EX-27, 2000-08-28
Previous: TUXIS CORP, NSAR-A, 2000-08-28
Next: ALLIANCE PHARMACEUTICAL CORP, 8-K, 2000-08-28



<TABLE> <S> <C>


<ARTICLE>                     6
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
Tuxis  Corporation  Semi-Annual  Report  and is  qualified  in its  entirety  by
reference to such financial statements.
</LEGEND>
<CIK>                         0000736952
<NAME>                        Tuxis Corporation
<MULTIPLIER>        1
<CURRENCY>          U.S. Dollar


<S>                                           <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 Jan-01-2000
<PERIOD-END>                                   Jun-30-2000
<EXCHANGE-RATE>                                   1.000
<INVESTMENTS-AT-COST>                             11,609,074
<INVESTMENTS-AT-VALUE>                            11,736,042
<RECEIVABLES>                                     249,288
<ASSETS-OTHER>                                    2,981
<OTHER-ITEMS-ASSETS>                              0
<TOTAL-ASSETS>                                    11,988,311
<PAYABLE-FOR-SECURITIES>                          0
<SENIOR-LONG-TERM-DEBT>                           0
<OTHER-ITEMS-LIABILITIES>                         943,935
<TOTAL-LIABILITIES>                               943,935
<SENIOR-EQUITY>                                   0
<PAID-IN-CAPITAL-COMMON>                          11,486,010
<SHARES-COMMON-STOCK>                             823,480
<SHARES-COMMON-PRIOR>                             799,151
<ACCUMULATED-NII-CURRENT>                         (466,430)
<OVERDISTRIBUTION-NII>                            0
<ACCUMULATED-NET-GAINS>                           (102,172)
<OVERDISTRIBUTION-GAINS>                          0
<ACCUM-APPREC-OR-DEPREC>                          126,968
<NET-ASSETS>                                      11,044,376
<DIVIDEND-INCOME>                                 8,419
<INTEREST-INCOME>                                 254,991
<OTHER-INCOME>                                    0
<EXPENSES-NET>                                    124,214
<NET-INVESTMENT-INCOME>                           139,196
<REALIZED-GAINS-CURRENT>                          82,678
<APPREC-INCREASE-CURRENT>                         (990,214)
<NET-CHANGE-FROM-OPS>                             (768,340)
<EQUALIZATION>                                    0
<DISTRIBUTIONS-OF-INCOME>                         139,196
<DISTRIBUTIONS-OF-GAINS>                          0
<DISTRIBUTIONS-OTHER>                             464,545
<NUMBER-OF-SHARES-SOLD>                           0
<NUMBER-OF-SHARES-REDEEMED>                       0
<SHARES-REINVESTED>                               24,329
<NET-CHANGE-IN-ASSETS>                            (1,097,143)
<ACCUMULATED-NII-PRIOR>                           0
<ACCUMULATED-GAINS-PRIOR>                         (186,776)
<OVERDISTRIB-NII-PRIOR>                           0
<OVERDIST-NET-GAINS-PRIOR>                        0
<GROSS-ADVISORY-FEES>                             34,627
<INTEREST-EXPENSE>                                6,714
<GROSS-EXPENSE>                                   124,214
<AVERAGE-NET-ASSETS>                              11,599,067
<PER-SHARE-NAV-BEGIN>                             15.19
<PER-SHARE-NII>                                   .17
<PER-SHARE-GAIN-APPREC>                           (1.20)
<PER-SHARE-DIVIDEND>                              (.17)
<PER-SHARE-DISTRIBUTIONS>                         0
<RETURNS-OF-CAPITAL>                              (.58)
<PER-SHARE-NAV-END>                               13.41
<EXPENSE-RATIO>                                   2.15




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission